Literature DB >> 29164574

Mechanism of As2O3 induces apoptosis of glioma U87 cells.

G-B Wang1, J-H Liu, J Hu, K Xue.   

Abstract

OBJECTIVE: To investigate the mechanism of arsenic trioxide (As2O3)-induced apoptosis of glioma cells.
MATERIALS AND METHODS: U87 cells were treated by different concentrations of As2O3 (8 μmol/L, 6 μmol/L, 4 μmol/L, 2 μmol/L, 1 μmol/L and 0.5 μmol/L) for 24 h, 48 h and 72 h, respectively. Cell viability was detected by 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay, and the appropriate dosage and time were screened. Transferase-mediated deoxyuridine triphosphate-biotin nick end labeling (TUNEL) was used to stain cells, followed by an investigation on the apoptosis of cells. In the study of molecular mechanism, the expression of p53 in the cells was determined by immunofluorescence, and then apoptosis-related factors, Fas, FasL and Bax, were tested using Real-time polymerase chain reaction (RT-PCR). Finally, the effect of As2O3 on apoptosis-related proteins, caspase-3 and caspase-9, was investigated by Western blotting.
RESULTS: As2O3 could significantly inhibit proliferation of U87 cells, and the result of TUNEL staining displayed As2O3 had the function of inducing apoptosis. Immunofluorescence results demonstrated that p53 was highly expressed in glioma cells, which was reduced after drug administration. The results of detection of apoptosis factors using RT-PCR revealed that mRNA expressions of Fas, FasL and Bax in the glioma cells were distinctly higher than those in the As2O3 group. The result of Western blotting indicated that caspase-3 and caspase-9 proteins were highly expressed in glioma cells. Analysis of variance showed that the difference between the control group and the As2O3 group was statistically significant (p<0.01).
CONCLUSIONS: As2O3 can inhibit proliferation of glioma cells and induce its apoptosis, which may be correlated with down-regulation of expressions of apoptosis-related factors, Fas, FasL and Bax, and apoptosis-related proteins, p53, caspase-3 and caspase-9.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29164574

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  3 in total

Review 1.  Current Advances of Nanomedicines Delivering Arsenic Trioxide for Enhanced Tumor Therapy.

Authors:  Mengzhen Yu; Yanwen Zhang; Meirong Fang; Shah Jehan; Wenhu Zhou
Journal:  Pharmaceutics       Date:  2022-03-30       Impact factor: 6.525

2.  Arsenic trioxide induces apoptosis and the formation of reactive oxygen species in rat glioma cells.

Authors:  Yuanyuan Sun; Chen Wang; Ligang Wang; Zhibo Dai; Kongbin Yang
Journal:  Cell Mol Biol Lett       Date:  2018-03-27       Impact factor: 5.787

Review 3.  Arsenic trioxide as a novel anti-glioma drug: a review.

Authors:  Yi Fang; Zhen Zhang
Journal:  Cell Mol Biol Lett       Date:  2020-09-24       Impact factor: 5.787

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.